NCT06031441 2026-06-02A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid TumorsGenentech, Inc.Phase 1 Recruiting250 enrolled